Psoriasis goals

Treatment goals for patients with psoriasis are to minimize signs such as plaques and scales, alleviate symptoms such as pruritus, reduce the frequency of flare-ups, and ensure appropriate treatment of associated conditions such as psoriatic arthritis or clinical depression, and minimize treatment-related morbidity. 

Since psoriasis is a chronic illness with no known cure, the goals of treatment focus on controlling the signs and symptoms of disease, including ... 

Create a care plan for this patient s psoriasis, including statement of the drug-related problems, goals of therapy, patient-specific detailed therapeutic plan, and monitoring plan and follow-up. 

The goals of therapy are to see an improvement in the condition of his psoriasis using a treatment regimen that is compliant with the patient s social needs. 

The type of lesion and whether the patient also has psoriatic arthritis are important issues in cleterinining therapy. Steroid topical creams, cyclosporine andmethotraxate are useful in treatment of psoriasis. Oral tazarotene, a non-biologic retinoid is pending FDA approval for moderate to severe psoriasis. As with most autoimmune disorder s, different patients respond differently and newer more targeted therapies are important goals. 

The most common areas for psoriasis in human are shown on the scalp[3, 4], Initially, a series of classical treatment is used to treat this disease but that attempt has been failed. Today, phototherapy and PDT have become a regular modality and effective way for psoriasis and actinic keratoses treatment[4]. In spite of the various by topical treatments available for the treatment of superficial skin disease in scalp skin, many patients not succeed to respond adequately or may develop side effects. The goal of PDT treatment of psoriasis and actinic keratoses is to cure or locally control the disease while minimizing complications in normal tissues and reducing pain regarding therapy by investigation the influence of optical properties of skin and hair. 

---